4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-22-020961
Options or other derivatives
- Director acquired 9,146 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Harel Ittai · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +9,146 | 9,146 | D |
Loading xslF345X03/doc4.xml…